Macroscopic 3D (A) and schematic (B) images of the structure of the amino-terminal domain of the NMDA receptor with a negative allosteric negative modifier in the active site.

  Part of: Severina HI, Georgiyants VA, Kovalenko SM, Avdeeva NV, Yarcev AI, Prohoda SN (2020) Molecular docking studies of N-substituted 4-methoxy-6-oxo-1-aryl-pyridazine-3-carboxamide derivatives as potential modulators of glutamate receptors. Research Results in Pharmacology 6(1): 69-82.